Literature DB >> 20584979

Phosphoinositide-dependent kinase 1 provides negative feedback inhibition to Toll-like receptor-mediated NF-kappaB activation in macrophages.

Bhagirath Chaurasia1, Jan Mauer, Linda Koch, Julia Goldau, Anja-Sterner Kock, Jens C Brüning.   

Abstract

Phosphoinositide-dependent kinase 1 (PDK-1) represents an important signaling component in the phosphatidylinositol 3-kinase (PI3K) pathway, which plays an essential role in controlling a coordinated innate immune response. Here, we show that mice with conditional disruption of PDK-1 specifically in myeloid lineage cells (PDK-1(Deltamyel) mice) show enhanced susceptibility to lipopolysaccharide (LPS)-induced septic shock accompanied by exaggerated liver failure. Furthermore, primary macrophages derived from PDK-1(Deltamyel) mice lack LPS- and Pam3CSK4-stimulated AKT activity but exhibit increased mRNA expression and release of tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6). Moreover, LPS- and Pam3CSK4-stimulated primary macrophages exhibit enhanced phosphorylation and degradation of IkappaBalpha. While immediate upstream Toll-like receptor 4 (TLR-4)-induced signaling, including IL-1 receptor (IL-1R)-associated protein kinase (IRAK) phosphorylation, is unaltered in the absence of PDK-1, macrophages from PDK-1(Deltamyel) mice exhibit prolonged ubiquitination of tumor necrosis factor receptor-associated factor 6 (TRAF-6) in response to LPS stimulation. These experiments reveal a novel PDK-1-dependent negative feedback inhibition of TLR-induced NF-kappaB activation in macrophages in vivo.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584979      PMCID: PMC2937543          DOI: 10.1128/MCB.00069-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  58 in total

Review 1.  How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.

Authors:  M Karin
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

Review 2.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

4.  Crohn's disease: genetic susceptibility, bacteria, and innate immunity.

Authors:  D A Van Heel; D P McGovern; D P Jewell
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

5.  IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation.

Authors:  Toby Lawrence; Magali Bebien; George Y Liu; Victor Nizet; Michael Karin
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

6.  Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1.

Authors:  A H Kim; G Khursigara; X Sun; T F Franke; M V Chao
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

7.  The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells.

Authors:  M R Williams; J S Arthur; A Balendran; J van der Kaay; V Poli; P Cohen; D R Alessi
Journal:  Curr Biol       Date:  2000-04-20       Impact factor: 10.834

8.  Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin.

Authors:  M M Monick; A B Carter; P K Robeff; D M Flaherty; M W Peterson; G W Hunninghake
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

9.  Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.

Authors:  M Guha; M A O'Connell; R Pawlinski; A Hollis; P McGovern; S F Yan; D Stern; N Mackman
Journal:  Blood       Date:  2001-09-01       Impact factor: 22.113

10.  Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells.

Authors:  J P Gratton; M Morales-Ruiz; Y Kureishi; D Fulton; K Walsh; W C Sessa
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

View more
  21 in total

Review 1.  Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Authors:  Jessica A Hamerman; Jessica Pottle; Minjian Ni; Yantao He; Zhong-Yin Zhang; Jane H Buckner
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

Review 2.  Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K.

Authors:  Ty Dale Troutman; J Fernando Bazan; Chandrashekhar Pasare
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

Review 3.  Crosstalk between insulin and Toll-like receptor signaling pathways in the central nervous system.

Authors:  Fatemeh Hemmati; Rasoul Ghasemi; Norlinah Mohamed Ibrahim; Leila Dargahi; Zahurin Mohamed; Azman Ali Raymond; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-01-25       Impact factor: 5.590

4.  Role of ghrelin-induced phosphatidylinositol 3-kinase activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2013-09-21       Impact factor: 4.473

5.  Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide.

Authors:  Urmila Maitra; Hui Deng; Trevor Glaros; Bianca Baker; Daniel G S Capelluto; Zihai Li; Liwu Li
Journal:  J Immunol       Date:  2012-06-15       Impact factor: 5.422

6.  Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae: activation of macrophages through Toll-like receptor 4.

Authors:  Feng-Ling Yang; Yu-Liang Yang; Pei-Chun Liao; Ju-Ching Chou; Keng-Chang Tsai; An-Suei Yang; Fuu Sheu; Tzu-Lung Lin; Pei-Fang Hsieh; Jin-Town Wang; Kuo-Feng Hua; Shih-Hsiung Wu
Journal:  J Biol Chem       Date:  2011-04-08       Impact factor: 5.157

7.  Molecular mechanism responsible for the priming of macrophage activation.

Authors:  Hui Deng; Urmila Maitra; Matt Morris; Liwu Li
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

8.  PI3Kγ is a molecular switch that controls immune suppression.

Authors:  Megan M Kaneda; Karen S Messer; Natacha Ralainirina; Hongying Li; Christopher J Leem; Sara Gorjestani; Gyunghwi Woo; Abraham V Nguyen; Camila C Figueiredo; Philippe Foubert; Michael C Schmid; Melissa Pink; David G Winkler; Matthew Rausch; Vito J Palombella; Jeffery Kutok; Karen McGovern; Kelly A Frazer; Xuefeng Wu; Michael Karin; Roman Sasik; Ezra E W Cohen; Judith A Varner
Journal:  Nature       Date:  2016-09-19       Impact factor: 49.962

9.  Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses.

Authors:  Emine Sahin; Stefan Haubenwallner; Mario Kuttke; Isabella Kollmann; Angela Halfmann; Alexander M Dohnal; Alexander B Dohnal; Li Chen; Paul Cheng; Bastian Hoesel; Elisa Einwallner; Julia Brunner; Julia B Kral; Waltraud C Schrottmaier; Kathrin Thell; Victoria Saferding; Stephan Blüml; Gernot Schabbauer
Journal:  J Immunol       Date:  2014-07-11       Impact factor: 5.422

10.  The target landscape of clinical kinase drugs.

Authors:  Susan Klaeger; Stephanie Heinzlmeir; Mathias Wilhelm; Harald Polzer; Binje Vick; Paul-Albert Koenig; Maria Reinecke; Benjamin Ruprecht; Svenja Petzoldt; Chen Meng; Jana Zecha; Katrin Reiter; Huichao Qiao; Dominic Helm; Heiner Koch; Melanie Schoof; Giulia Canevari; Elena Casale; Stefania Re Depaolini; Annette Feuchtinger; Zhixiang Wu; Tobias Schmidt; Lars Rueckert; Wilhelm Becker; Jan Huenges; Anne-Kathrin Garz; Bjoern-Oliver Gohlke; Daniel Paul Zolg; Gian Kayser; Tonu Vooder; Robert Preissner; Hannes Hahne; Neeme Tõnisson; Karl Kramer; Katharina Götze; Florian Bassermann; Judith Schlegl; Hans-Christian Ehrlich; Stephan Aiche; Axel Walch; Philipp A Greif; Sabine Schneider; Eduard Rudolf Felder; Juergen Ruland; Guillaume Médard; Irmela Jeremias; Karsten Spiekermann; Bernhard Kuster
Journal:  Science       Date:  2017-12-01       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.